Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells

Neoplasia

Volumn 9, Issue 9, 2007, Pages 745-754

  Barraclough, Jane ^a   Hodgkinson, Cassandra ^a   Hogg, Alison ^a   Dive, Caroline ^a   Welman, Arkadiusz ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

c Src; c Yes; Colon cancer; Motility; Proliferation

Indexed keywords

PROTEIN KINASE YES;

ANALYTIC METHOD; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 34948888234     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07442     Document Type: Article

References (31)

1. Thomas SM and Brugge JS (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13, 513-609.
2. Summy JM and Gallick GE (2003). Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22, 337-358.
3. Frame MC (2002). Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602, 114-130.
4. Talamonti MS, Roh MS, Curley SA, and Gallick GE (1993). Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 91, 53-60.
5. Cartwright CA, Meisler AI, and Eckhart W (1990). Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 87, 558-562.
6. Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J, Yu H, Garcia R, Jove R, and Yeatman TJ (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15, 3083-3090.
7. Iravani S, Mao W, Fu L, Karl R, Yeatman T, Jove R, and Coppola D (1998). Elevated c-Src protein expression is an early event in colonic neoplasia. Lab Invest 78, 365-371.
8. Park J, Meisler AI, and Cartwright CA (1993). c-Yes tyrosine kinase activity in human colon carcinoma. Oncogene 8, 2627-2635.
9. Muro S, Takemasa I, Oba S, Matoba R, Ueno N, Maruyama C, Yamashita R, Sekimoto M, Yamamoto H, Nakamori S, et al. (2003). Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol 4, R21.
10. Han NM, Curley SA, and Gallick GE (1996). Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases. Clin Cancer Res 2, 1397-1404.
11. Summy JM, Sudol M, Eck MJ, Monteiro AN, Gatesman A, and Flynn DC (2003). Specificity in signaling by c-Yes. Front Biosci 8, s185-s205.
12. Clump DA, Qazi IH, Sudol M, and Flynn DC (2005). c-Yes response to growth factor activation. Growth Factors 23, 263-272.
13. Irby R, Mao W, Coppola D, Jove R, Gamero A, Cuthbertson D, Fujita DJ, and Yeatman TJ (1997). Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Cell Growth Differ 8, 1287-1295.
14. Jones RJ, Avizienyte E, Wyke AW, Owens DW, Brunton VG, and Frame MC (2002). Elevated c-Src is linked to altered cell - matrix adhesion rather than proliferation in KM12C human colorectal cancer cells. Br J Cancer 87, 1128-1135.
15. Welman A, Cawthorne C, Ponce-Perez L, Barraclough J, Danson S, Murray S, Cummings J, Allen TD, and Dive C (2006). Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivo. Neoplasia 8, 905-916.
16. Park J and Cartwright CA (1995). Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol Cell Biol 15, 2374-2382.
17. Summy JM and Gallick GE (2006). Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12, 1398-1401.
18. Welman A, Cawthorne C, Barraclough J, Smith N, Griffiths GJ, Cowen RL, Williams JC, Stratford IJ, and Dive C (2005). Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expression. J Cell Biochem 94, 1148-1162.
19. Welman A, Barraclough J, and Dive C (2006). Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2. Nat Protoc 1, 803-811.
20. Cawthorne C, Swindell R, Stratford IJ, Dive C, and Welman A (2007). Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model. J Biomol Tech 18, 120-123.
21. Veillette A, Foss FM, Sausville EA, Bolen JB, and Rosen N (1987). Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Res 1, 357-374.
22. Hirsch CL, Smith-Windsor EL, and Bonham K (2006). Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. Int J Cancer 118, 547-554.
23. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, and Yeatman TJ (1999). Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21, 187-190.
24. Kmiecik TE and Shalloway D (1987). Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
25. Liang CC, Park AY, and Guan JL (2007). In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329-333.
26. Alvarez RH, Kantarjian HM, and Cortes JE (2006). The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors. Cancer 107, 1918-1929.
27. Serrels A, Macpherson IR, Evans TR, Lee FY, Clark EA, Sansom OJ, Ashton GH, Frame MC, and Brunton VG (2006). Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. Mol Cancer Ther 5, 3014-3022.
28. Liu L, Zhang Q, Zhang Y, Wang S, and Ding Y (2006). Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of human colorectal cancer cell line. Neoplasia 8, 917-924.
29. Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, et al. (2005). Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7, 545-555.
30. Summy JM, Qian Y, Jiang BH, Guappone-Koay A, Gatesman A, Shi X, and Flynn DC (2003). The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src. J Cell Sci 116, 2585-2598.
31. Sakamoto M, Takamura M, Ino Y, Miura A, Genda T, and Hirohashi S (2001). Involvement of c-Src in carcinoma cell motility and metastasis. Jpn J Cancer Res 92, 941-946.